D C McFadden

Statistics

Publications

Citations

279

H-Index

Active since

1992

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

D C McFadden is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pneumocystis infection, infectious diseases, and antimicrobial pharmacology.

Publications per year

1992–2005

Publications

Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species.

Dennis M. Schmatz, George K. Abruzzo, Maryann Powles et al. · The Journal of Antibiotics · 1992 · 64 citations · Full text

Life Sciences, Medicinal Chemistry, Microbiology +10

Mouse model for Pneumocystis carinii pneumonia that uses natural transmission to initiate infection

Maryann Powles, D C McFadden, L A Pittarelli et al. · Infection and Immunity · 1992 · 47 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

New semisynthetic pneumocandins with improved efficacies against Pneumocystis carinii in the rat

Dennis M. Schmatz, Maryann Powles, D C McFadden et al. · Antimicrobial Agents and Chemotherapy · 1995 · 44 citations

Medicine, Pharmacology, Pharmacotherapy +11

Antipneumocystis activity of water-soluble lipopeptide L-693,989 in rats

Dennis M. Schmatz, Maryann Powles, D C McFadden et al. · Antimicrobial Agents and Chemotherapy · 1992 · 31 citations

Veterinary Medicine, Infectious Diseases, Pharmacology +15

Treatment and prevention of Pneumocystis carinii pneumonia and further elucidation of the P. carinii life cycle with 1,3-beta-glucan synthesis inhibitor L-671,329.

Dennis M. Schmatz, Maryann Powles, D C McFadden et al. · PubMed · 1992 · 31 citations

Pharmacy, Infectious Diseases, Pharmacology +14

1–5 of 9